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Optimization of three enzyme immunoassays of very high sensitivity using three anti-
prolamin monoclonal antibodies (MAbs) (13B4, 11C4 and 12A1) is presented here. These
MAbs are specific for those prolamins toxic for coeliac patients, as determined by
immunoblotting analysis. Biotinylated MAbs were used in two of the assays. In a compet-
itive ELISA, the binding of each biotinylated MAb to a gliadin-coated solid phase was
inhibited by gliadin in the fluid phase. The best result was obtained using the biotinylated
MAbl3B4 (detection limit: 20 ng ml-1). With regard to capture ELISA, we tested the
performance of the three MAbs. In this sandwich ELISA, the MAb used for antigenic
capture was the same as that used as secondary biotinylated antibody. The MAbl2Al had
the best performance (detection limit: 1 ng ml-1). The use of biotin-labelled gliadin in a
quantitative immunoassay with a detection limit of 5 ng ml-1 is also reported. This assay
involves an antigenic capture using the MAbl2Al followed by a competition between
biotinylated and non-biotinylated gliadin. We have found the use of the streptavidin-biotin
interaction as signal amplification system to be very useful. This technique, as far as we
know, has not been previously reported for gliadin quantification.
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INTRODUCTION
Coeliac disease (CD) is one of the most frequent chronic gastrointestinal disorders in both
children and adults. The highest prevalence, 1:184, was found in an Italian multi-centre
study (Catassi et ah, 1996). CD occurs in genetically susceptible individuals as a result of
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the ingestion of food containing prolamins of wheat, barley, rye and probably oat (Marsh,
1992). Ingestion of minimal amounts of these proteins may produce the characteristic
histological alterations of the small bowel mucosa (Troncone & Auricchio, 1991). Most
patients show a rapid improvement of their clinical conditions when prolamins are removed
from their diet. Consequently, a strict gluten-free diet (GFD) is the only possible treatment
for coeliac patients (Dinari et al., 1992). Clinical presentation and mucosal histology show
a great variability among non-treated coeliac patients. Moreover, there is no agreement
about the maximal amount of gluten that may be ingested without affecting the mucosa or
producing relapse of symptoms.
Wheat proteins are widely used in the food industry to improve product quality because
of their particular physicochemical properties. In some cases, these proteins can be present
in minimal amounts. Wheat starch is also used as an excipient in medicines; consequently,
gliadins can be found in pharmaceutical products (Miletic et al., 1994).
Several methods for the analysis and quantification of prolamins have been developed
using both polyclonal and monoclonal antibodies (MAbs) (Howdle & Losowsky, 1990).
Nevertheless, in these assays, many drawbacks arise mainly as result of the very low
solubility of prolamins in solvents compatible with antigen-antibody interaction (Skerritt &
Martinuzzi, 1986). The tendency of prolamins to form macromolecular aggregates, their
high homology with the resulting strong cross-reactivity and the difficulty to prepare
isolated components are factors causing problems during the characterization of antibody
reactivity as well as in the development of assays of high specificity and sensitivity
(Festenstein et al., 1987; Brett et al., 1990). Furthermore, many commercial foodstuffs
undergo thermal treatment during manufacturing, leading to conformational changes of
proteins and changes in their immunochemical reactivity. In this case, some of the methods
reported are unable to detect gliadin in processed food, as reported by Friis (1988). Using
some antibodies, cross-reactivity with proteins non-toxic for coeliac patients—leading to
false-positive results—have also been documented in quantitative methods (e.g. Troncone
et al., 1986).
It is clear that the optimization of a quantitative immunoassay that fulfils the require-
ments of specificity, accuracy and detectability is very difficult to achieve. Immunochemical
and structural studies, as well as economical and legal reasons, and the need to ensure the
composition of products and guarantee the fulfilment of GFD requirements make the
development of highly sensitive analytical methods imperative.
To this end, we tested the use of the highly sensitive biotin-streptavidin system. The
preparation of antigens and biotinylated MAbs is easy because biotin can be coupled under
such mild conditions that generally their biological activity remains unchanged. Since
streptavidin has a very high affinity for biotin (a reaction that is also multivalent) a great
signal amplification is achieved (Avrameas, 1992). As far as we know, this system has not
been previously used in gliadin quantification.
In this article, we show the characterization of anti-prolamins MAbs and the development
of three different quantitative ELISAs of high detection limit, using both biotin-labelled
anti-prolamin MAbs and biotinylated gliadin.
MATERIALS AND METHODS
Preparation of Protein Extracts
Protein extracts were prepared from wheat, barley, rye, triticale, oat, soy, rice and maize
flour extracted with 70% (v/v) aqueous ethanol (10 ml g"1, 2 h at room temperature) after
removal of the albumin-globulin fraction using 0.15 M-NaCl (10 ml g"1, four times for
1 h each, at room temperature). Samples were centrifuged at 10 000 X g, 15 min at 8°C after
each incubation step. The prolamin fraction (ethanol 70% soluble proteins) was obtained as
the supernatant of the last centrifugation step.
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Preparation of Gliadin Standard Solution
Gliadin (Sigma Chemical Co) was dissolved in 70% aqueous ethanol at approximately
2 mg ml"1. The solution was first filtered through filter paper (Whatman no. 1) and then
through a 0.22-fim Nucleopore membrane (Millipore, MA, USA). A clear and stable gliadin
solution was obtained using this procedure. Kjeldahl's method was employed to determine
the protein concentration in the standard solution.
Production of Anti-prolamin MAbs
BALB/c mice (8 weeks old) were intraperitoneally immunized with commercial gliadin
(Sigma Chemical Co., MO, USA) in phosphate-buffered saline (PBS) with Freund's
complete adjuvant (0.2 ml, 50 fig protein). They were later inoculated every 3 weeks during
4 months with gliadin prepared in Freund's incomplete adjuvant (0.1 ml, 20 fig ml"1).
Serum samples were analyzed after 7-10 days of the last booster. The mouse with the
highest antibody titre was chosen for fusion. MAbs were derived by somatic cell hybridiza-
tion of NSO myeloma cells with spleen cells from a hyperimmune mouse as described by
Kohler and Milstein (1975). Supernatant screening was performed with an indirect ELISA
using plates coated with gliadin standard solution (10 fig ml"1). The isotypes of the MAbs
obtained were determined by double diffusion of culture supernatant with commercial
anti-isotype sera. MAbs 11C4, 12A1 and 13B4 were purified from the corresponding ascitic
fluid by anion exchange fast performance liquid chromatography (FPLC) using a Mono Q
HR5/5 column (LKB-Pharmacia, Upsala, Sweden). Purity was analyzed by SDS-PAGE and
isoelectrofocusing.
Preparation of Biotin-Iabelled MAb
MAbs were biotin conjugated according to the method of Harlow and Lane (1988). Briefly,
purified MAbs were dissolved and dialyzed against 0.1 M-sodium borate buffer, pH 8.8. A
solution of each MAb (1 mg ml"1) was incubated with n-hydroxysuccinimido-biotinami-
docaproate ester (Sigma) (100 fig of ester/mg of MAb), at room temperature for 4 h.
Reaction was stopped by adding 1 M-NH4C1 (20 fd/250 fig of ester). Unconjugated biotin
was eliminated by chromatography using a P-10 column (Pharmacia). Finally, the biotiny-
lated MAb was lyophilized and stored at — 20°C.
Preparation of Biotin-Iabelled Gliadin
Commercial gliadin (Sigma) was dissolved in 0.001 M-NaOH and then filtered through a
nitrocellulose membrane (0.45 fim). This solution was dialyzed against 0.1 M-sodium borate
buffer, pH 8.8, and was biotin conjugated as described previously.
Sequential Competitive ELISA
A competitive assay using MAbs was performed according to a similar procedure to that
described by Chirdo et al. (1995). Polystyrene strips (Maxisorp, Nunc, Denmark) were
coated for 16 h at 4°C with 50 /il/well of gliadin in PBS solutions (10 fig ml ~ ') . Wells were
washed with PBS containing 0.05% (v/v) Tween 20 (PBS-T) and non-specific binding sites
were blocked by incubating with 200 /il/well of 3% (w/v) dry skimmed milk in PBS for
2 h at 37°C. After each incubation step, wells were washed with PBS-T solution. Gliadin
standard solutions and biotin-labelled MAbs were dissolved in PBS-T containing 1% (w/v)
of dry skimmed milk (diluent solution). Solutions containing equal volumes of antigen and
antibody solutions were mixed and incubated, for 2 h at 37°C in plastic tubes (preincuba-
tion). Then, 50 /il/well of each sample were incubated foF 30 min at 37°C in the
gliadin-coated wells. After washing, plates were incubated with conjugated streptavidin-
alkaline phosphatase (Sigma) (1 h at 37°C). After three cycles of washing with PBS-T and
one with substrate buffer (10% diethanolamine, 0.01% MgCl2, pH 9.8), colour reaction was
developed with 50 ^I/well of p-nitrophenylphosphate (PNPP)(1 mg ml"1). After 30 min,
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the colour reaction was stopped with 0.1 M-EDTA (50 /il/well). Optical density was
determined at 405 nm (OD405). Absorbance values were transformed by logit function
(Tijssen, 1985).
Capture ELISA
Polystyrene strips (Maxisorp, Nunc) were coated for 16 h at 4°C with 50 ^I/well of MAbs
in PBS solutions (20 fig ml"1). Wells were washed and blocked as previously described;
then gliadin standard solutions of different concentrations were incubated for 1 h at 37°C.
After washing, wells were incubated with the appropriate dilution of biotin-labelled MAb
(in each assay, the same MAb used in the capture) for 1 h at 37°C. Incubation with
conjugated streptavidin-alkaline phosphatase and the colour were developed as already
described. Results were expressed as optical density at 405 nm (percentage of maximal
binding) versus log of gliadin concentration.
Competitive ELISA Using Biotin-labelled Gliadin
Polystyrene strips (Maxisorp, Nunc) were coated for 16 h at 4°C with 50 /il/well of MAbs
in PBS solution (20 fig ml"1). Wells were washed and blocked as previously described.
Calibration curves were prepared using gliadin standard solutions diluted in a solution
containing biotin-labelled gliadin (1 fig ml"1) and incubated for 1 h at 37°C. Incubation
with conjugated streptavidin—alkaline phosphatase and the colour were developed as already
described. Results were expressed as logit function versus log of gliadin concentration.
Immunoblotting Analysis of Protein Extracts
Protein extracts were separated by SDS-PAGE (10-15% polyacrylamide gradient concen-
tration) according to Laemmli (1970). Proteins were transferred to nitrocellulose sheets
according to Towbin (1979). Membranes were then blocked by incubating with a solution
of 1% (w/v) dry skimmed milk in TBS (0.05 M-Tris-HCl, 0.150 M-NaCl, pH 7.4) for 2 h
at 37°C. After washing, membranes were incubated with the purified MAbs at the
appropriate dilution in 0.5% (w/v) of dry skimmed milk in TBS for 1 h at 37°C. After
washing, membranes were incubated with conjugated rabbit anti-mouse immunoglobulin
peroxidase (Dako, Denmark) (1 h at 37°C). After three cycles of washing with TBS, the
colour was developed with 4-chloro-l-naphthol and H2O2.
Immunoblotting from Proteins Resolved by A-PAGE
A prolamin extract from wheat flour was separated by PAGE at pH 3.1 (A-PAGE)
according to Lafiandra and Kasarda (1985). Proteins were transferred to nitrocellulose
membranes using an acidic buffer (0.1 M-lactic acid) for 1 h at 250 mA. Western blot
analysis was performed as described above.
RESULTS
Characterization of MAb Specificity
Thirty hybridomas secreting anti-prolamin MAbs were obtained (18 IgGi, nine IgM, two
IgG3 and one IgA). In this study, three IgGi MAbs termed 13B4, 12A1 and 11C4 were
selected according to their pattern of recognition as analyzed by immunoblotting.
Figure 1 shows the immunoblotting obtained with the ethanol 70% soluble protein
fractions of wheat, barley, rye, triticale, oat, soy, rice and maize. It can be seen that MAbs
11C4 and 12A1 exhibit a similar pattern of reactivity. Both MAbs have a broad recognition
pattern and react with components of most groups of prolamins from wheat, barley, rye and
triticale. These MAbs recognize a-, /?- and y-gliadins, and two intense bands from the
to-gliadin region (50-55 kDa) (lane 1). In lane 2, (barley prolamins), two groups of bands
are detected: one close to 50 kDa, corresponding to C-hordeins, and the other in the region
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FIG. 1. Immunoblotting analysis after SDS-PAGE separation. Protein fractions (ethanol 70% soluble) from
wheat (lane 1), barley (lane 2), rye (lane 3), triticale (lane 4), oat (lane 5), soy (lane 6), rice (lane 7)
and maize (lane 8) were separated by SDS-PAGE (10-15% acrylamide gradient concentration) and
revealed with MAb 12A1, 11C4 and 13B4.
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FIG. 2. Immunoblotting analysis after A-PAGE separation. Gliadin fractions separated by acid-PAGE and
revealed with MAbl3B4 (lane 1), MAbllC4 (lane 2), MAbl2Al (lane 3) and rabbit anti-prolamin
serum (lane 4).
of 40 kDa, corresponding to B-hordeins. A reactivity in the region of 50-40 kDa and
30 kDa is observed in rye proteins (lane 3), corresponding to co-secalins and y-secalins.
Both MAbs show reactivity against triticale proteins (lane 4), mainly in the homologous
components of wheat and rye. MAbllC4 also reacts slightly with some oat components
(lane 5).
MAbl3B4 exhibits high reactivity against wheat and triticale proteins (lanes 1 and 4,
respectively). Intense bands can be observed in the regions of a-, /?- and y-gliadins, on the
contrary, a weak reactivity with barley and rye prolamins is observed (lanes 2 and 3,
respectively).
The results show that these three MAbs react with proteins from those cereals toxic for
coeliac patients, whilst reactivity against proteins that do not induce CD such as soy, rice
and maize was undetectable.
MAb reactivity was also analyzed by immunoblotting after A-PAGE separation (Figure
2). Although the three MAbs recognize a-, /?- and y-gliadins, significant differences can be
observed. MAbl3B4 (lane 1) reacts weakly with some o-gliadins. MAbllC4 (lane 2)
recognize a-, /?- and y-gliadins, but in a more restricted way. Mabl2Al (lane 3) reacts
strongly with some y- and tu-gliadins. Lane 4 shows the reactivity of a rabbit anti-prolamin
serum that recognizes components of all groups of gliadins (lane 4) (Chirdo et al., 1995).
Optimization of Three Different ELISAs for Gliadin Determination
Sequential competitive ELISA. To optimize a sequential competitive ELISA using immo-
bilized gliadin, a titration assay was performed (Figure 3(a)). The working dilution
biotinylated MAb was established as the one that produces 80-90% of maximal binding,
corresponding to: 13B4= 1/3200, 11C4= 1/200 and 12A1 = 1/1600.
In the quantitative assay, calibration curves were calculated from OD405 values trans-
formed by the logit function (Figure 3(b)). Assay using the MAbl3B4 yielded the best
results. This assay presents a broad range of linear response and a high sensitivity,
parameters of the assay are as follows: 50% inhibition (logit p = 0): 120 ng ml"1 and a
detection limit of 20 ng ml"1 (Mest, confidence: 99%). MAbs 11C4 and 12A1 led to assays
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FIG. 3. Competitive ELISA. (a) Titration curves of biotinylated MAbs in plates coated with gliadin
(10 fig ml ~'). (b) Calibration curves. [G]: gliadin concentration (range: 12 ng ml ~ '-9 fig ml ~'). MAb:
13B4 (•) , 12A1 (O), 11C4 (•). Symbols represent the mean value of triplicate experiments.
with lower sensitivity and detectability (50% inhibition: 500 ng ml"1 and 1.4 fig ml"1,
respectively) and present a low slope in the line of the linear regression.
Capture ELISA. This capture design involves the use of the same MAb for both antigenic
capture and as the secondary biotinylated antibody. At first, we analyzed the concentration
of MAbs used for coating. Figure 4(a) shows that the adequate coating concentration of
MAbs is 20 fig ml"1. Under this condition and using gliadin at 10 fig ml"1 (saturant
concentration), it can be seen that MAbl2Al leads to higher OD405 values (approximately
1.5) than those obtained with MAbllC4. No positive response was observed when
MAbl3B4 was used.
Figure 4(b) shows the calibration curve in capture ELISA using a 20 fig ml"1 MAb
solution for coating. The best result was obtained using MAbl2Al. The sigmoid curve
shows a working range of 0.3 to 50 ng ml ~', and a detection limit of 1 ng gliadin/ml (Mest,
confidence: 99%). The assay using the MAbllC4 presents a lower detectability as judged
by its shifting to higher gliadin concentrations.
In Figure 4(b), we have compared the performance of ELISA results using the biotiny-
lated MAbs and the commercial assay (Gluten assay Kit, Cortecs Diagnostic, UK).
According to producers, the commercial assay has a detection level of 160 ng gliadin/ml.
It can be seen that the curve obtained using the commercial kit appears at a higher gliadin
concentration, showing a lower detectability than the capture ELISA using the MAbl2Al.








FIG. 4. Capture ELISA. (a) ELISA results using different MAb concentration for coating, (b) Calibration
curves. [G]: gliadin concentration (range: 150 pg ml" '-27 /*g ml"'). MAb: 13B4 (•) , 12A1 (O), 11C4
(•) , Commercial Kit (Gluten assay Kit, Cortecs Diagnostic, UK) (•) . Symbols represent the mean
value of triplicate experiments.
Competitive ELISA using biotin-labelled gliadin. To test the use of biotinylated gliadin as
a marker for the antigen-antibody interaction, we performed a competitive ELISA. To this
end, plates were separately coated with the three MAbs under study, then biotinylated
gliadin and non-labelled gliadin were allowed to compete for the antibody binding sites in
the solid phase. Finally, the reaction was developed with streptavidin-alkaline phosphatase.
Figure 5(a) shows that all MAbs efficiently captured the biotinylated gliadin. After
determining the appropriate biotinylated gliadin concentration (1 fig ml"1), a competitive
ELISA was performed. In this assay, the concentration of both MAbs and biotinylated
gliadin are critical in achieving a high detectability assay. The results shown in Figure 5(b)
show that the assay using the MAbl2Al presents the best performance with 50% inhibition
at 40 ng gliadin/ml and a detection limit of 5 ng gliadin/ml. MAbl3B4 presents a slightly
lower detectability (50% inhibition = 110 ng gliadin/ml). The assay using the MAbllC4
shows only poor detectability (50% inhibition = 900 ng gliadin/ml).
DISCUSSION
Several methods based on polyclonal antibodies (PAbs) and MAb technology have been
used in the immunochemical analysis of prolamins (Ellis et al., 1989; Skerritt & Lew, 1990)
and in the quantification of gliadin in foodstuffs manufactured for coeliac patients (Howdle
& Losowsky, 1990). Some manufactured products (food and medicines) contain small
amounts of prolamins, thus, high detectability methods are necessary to certify that the
resulting products are gluten free.
Among the different methods published, Skerritt and Smith (1985) developed a method
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FIG. 5. Competitive ELISA using biotinylated-gliadin. (a) Binding analysis of biotinylated gliadin (bG) to
MAbs in solid phase (20 fig mP ' ) . (b) Calibration curves. [G]: gliadin concentration (range:
1.2 ng ml" '-20 fig ml"'), compited with biotinylated gliadin at 1 ng ml"' . MAb: 13B4 (•) , 12A1
(O), 11C4 (•) . Symbols represent the mean value of triplicate experiments.
based on MAbs that allows the evaluation of thermally treated samples, but has only limited
sensitivity. Troncone et al. (1986) developed a capture ELISA with PAbs that exhibits a
high detectability, but it showed cross-reactivity with non-toxic prolamins from rice and
maize. Friis (1988) using PAbs developed a competitive ELISA which in spite of being able
to detect up to 10 ng gliadin/ml cannot be used on thermally processed food.
The co-gliadins, involving only 10-15% of total gliadins, are the most heat-resistant
prolamins. An anti-co-gliadin MAb was used to develop a test (detection level of 160 ng
gliadin/ml) able to detect gliadin in thermally treated food (Skerritt & Hill, 1990a).
Nevertheless, in the determination of gliadin in very-low gluten content products or in food
having partially lost protein reactivity, the use of high-affinity antibodies, able to detect
components from most gliadin groups, as well as totally or partially denatured proteins,
would be more adequate (Millis et al., 1995).
Ellis et al. (1994) reported a capture ELISA of high sensitivity (15 ng gliadin/ml) that
detects, with different affinity, prolamins of wheat, barley, rye and oat. We have recently
published the optimization of a sequential competitive ELISA using anti-gliadin PAbs,
specific for toxic prolamins, that presents very high detectability (1 ng gliadin/ml), and can
be used to quantify gliadin even in processed food (Chirdo et al., 1995, Rumbo et al.,
1996).
In the study presented here, we chose three MAbs (13B4, 11C4 and 12A1), according to
their specificity as characterized by immunoblotting. MAbs 12A1 and 11C4 recognize most
of the gliadins and glutenins, as well as several hordeins and secalins. Conversely,
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MAbl3B4 shows an intense reactivity against gliadins, but a very low one against
prolamins from barley and rye (Figure 1). Immunoblotting analysis after A-PAGE separ-
ation showed that the three MAbs detect components of all groups of gliadins. MAbl2Al
shows a marked reactivity against several co-gliadins, while MAbs 13B4 and 11C4 react
slightly with these proteins (Figure 2).
Analysis of MAb reactivity by immunoblotting indicates that these three MAbs are
specific for toxic cereal proteins, whereas they do not react with proteins harmless to CD.
Wheat prolamins present wide regions of repetitive sequences (Shewry & Tatham, 1990)
which induce a strong humoral immune response and determine the cross-reactivity of these
proteins (Festenstein et al., 1987; Brett et al., 1990). It can be concluded, from the
immunoblotting analysis (Figures 1 and 2), that the three MAbs under study recognize
repetitive sequences. Different specific anti-prolamin sera and MAbs reported by other
authors, and most of the MAbs from our panel (not shown), indicate that, irrespective of
the strategy employed in the immunization (crude gliadins, purified fractions or synthetic
peptides) or in the screening procedure, most of the antibodies prepared have a broad
recognition pattern and react with different repetitive sequences (Skerritt & Underwood,
1986; Festenstein et al., 1987; Ellis et al., 1989; Brett et al., 1990; Skerritt & Hill, 1990b;
Millis et al., 1995).
Gliadin purification is cumbersome, making immunoblotting the method most commonly
used to study the reactivity of anti-prolamin MAbs (Skerritt & Underwood, 1986; Skerritt,
1988). Nevertheless, it must be considered that experimental conditions influence MAbs'
reactivity assignation, for instance, at high concentrations, low-affinity interactions can be
detected, variations in MAb concentration can substantially modify the antibody recognition
pattern (Donovan et al., 1989). MAb reactivity can also be lost when proteins are separated
under denaturing conditions (SDS-PAGE with reducing agents). This was observed with
anti-gliadin MAbs, particularly with MAbs that detect S-poor prolamins (Brett et al., 1990).
To develop immunoassays of high sensitivity, the avidin-biotin system has been used
(Avrameas, 1992). The simple procedure to conjugate biotin to antigens and antibodies, the
high biotin-avidin association constant and the resulting large amplification of the enzy-
matic signal makes it possible to have a highly sensitive method. We tested the use of this
amplification system by biotin conjugation of the three MAbs under study and commercial
gliadin, and three different ELISA methods were thus optimized.
Sequential competitive ELISAs were performed using the three biotinylated MAbs.
Using the MAbl3B4, a high detectability quantitative assay was obtained (Figure 3(b)). Its
detection limit is 20 ng gliadin/ml, corresponding to 2 mg gluten/100 g of dry product (at
1:50 sample dilution). A competitive assay using an anti-tw-gliadins MAb (detection
limit = 25 mg gluten/100 g) was reported by Hill and Skerritt (1990). On the contrary, the
other two MAbs (11C4 and 12A1) produced assays with a lower detectability.
Compared with a simple inhibition ELISA, the sequential competitive ELISA involves an
extra incubation step which leads to an increase in the detection capability of the test. This
effect was analyzed using anti-gliadin PAbs in our previous work (Chirdo et al., 1995). This
assay presents a detection limit of 1 ng gliadin/ml corresponding to 0.1 mg gliadin/100 g
of dry product at 1/50 sample dilution.
When capture ELISA was performed, it was observed that the MAbl2Al produced the
best results. This assay presented a calibration curve with a broad range of lineal response
(0.3-50 ng ml"') and a detection limit of 1 ng gliadin/ml (0.05 mg gluten/100 g at 1:50
of dry product sample dilution). The capture ELISA adopted as official method by the
AOAC (Skerritt & Hill, 1991) has a detection limit of 160 ng gliadin/ml (Figure 4(b)).
An interesting result was observed when MAbl3B4 was used in capture ELISA (Figure
4(a)). Even though this MAb led to the best result in the competitive assay, it showed a poor
performance in a capture ELISA. In some cases, the lack of biological activity of the MAbs
could result from structural changes and denaturation due to hydrophobic interactions with
the plastic surface (Jitsukawa et al., 1989). Almost a 90% decrease in activity was observed
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with some MAbs, whereas in other cases, the reactivity was completely lost (Butler et al.,
1993). Nevertheless, we could not find significant differences when biotinylated gliadin was
captured by any of the three MAbs (Figure 5(a)). In spite of the fact that MAbl3B4 is as
able as the other two in capturing antigen, it proved to be useless for sandwich ELISA. This
result suggests that conformational changes due to adsorption to the solid phase are not the
reason why the MAbl3B4 cannot be used in capture ELISA. According to the immunoblot-
ting results, MAbl3B4 recognizes epitopes localized in repetitive sequences present in
several prolamins. Since this capture ELISA involves the use of the same antibody in the
capture as well as secondary biotinylated-antibody, results may be explained by considering
that MAbl3B4 recognizes an epitope present at low density or epitopes not easily reached
for antibody interaction.
Since it was possible to use biotinylated gliadin as a marker of binding of the
anti-prolamins MAbs (Figure 5(a)), we developed a competitive ELISA using plates coated
with a MAb for antigenic capture. The competition between biotinylated and non-biotiny-
lated gliadin was then determined. Figure 5(b) shows a broad range of linear response
achieved with the three MAbs. The best result was obtained using MAbl2Al. The
parameters of the assay indicate that this assay shows a 50% inhibition at 40 ng gliadin/ml
and a detection limit of 5 ng gliadin/ml, corresponding to 0.5 mg gluten/100 g of dry
product (at 1:50 sample dilution). A lower detectability was obtained with MAbs 13B4 and
11C4.
The assay described, employing biotinylated gliadin, can be useful for immunochemical
studies of prolamins, since native labelled-gliadin can compete with extracts of prolamins,
gliadin submitted to different conditions (e.g. thermal treatments) or with prolamin peptides.
CONCLUSIONS
In this study, we have characterized the reactivity of three anti-prolamin MAbs (13B4,
12A1 and 11C4). Results show that these three MAbs are specific for protein toxic for
coeliac patients while they do not react against proteins from vegetables non-related to CD,
such as soy, rice and maize.
Furthermore, we have shown the use of the streptavidin-biotin amplification system
employing both biotinylated MAbs and biotin-labelled gliadin. To our knowledge, this is
the first report about the use of this amplification system in gliadin quantification.
Three different ELISAs using the MAbs 13B4, 12A1 and 11C4 were optimized. Even
though each MAb recognizes repetitive sequences, when they were employed in different
ELISA, designs led to quite different results.
The three optimized ELISAs present high detectability. Two of these assays employed
biotinylated MAbs. In competitive ELISA, the best result was achieved by using MAbl3B4
(detection limit = 20 ng ml" ') . In capture ELISA, the MAbl2Al yielded the best perform-
ance (detection limit = 1 ng ml"1).
We also show the use of biotinylated gliadin in a competitive assay on plates coated with
a MAb. Using the MAbl2Al, up to 5 ng gliadin/ml could be detected.
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